DYNT (dynatronics.com) Market Value to Book Value Ratio

dynatronics.com (DYNT) - corporate logo

Dynatronics Corporation (DYNT) is expanding the rehabilitation sector through synergy with clinics. The price-to-book ratio illustrates the current asset valuation, where 0.15 indicates the level of this metric. However, weak pricing power in tenders limits margins, while the shift toward organic growth following restructuring focuses the company on internal cost optimization.

Market Capitalization to Net Assets: dynatronics.com (DYNT) for 07/04/2022 - 08/04/2024
Finished products of Dynatronics Corporation

The operational activities of Dynatronics Corporation (DYNT) in the US domestic market correlate directly with the company's market-to-book value ratio. This indicator compares share price to net assets to determine a fair business valuation. The metric measures the market premium or discount relative to the actual value of assets. Due to its isolation from geopolitical risks, the volatility of this figure reflects only internal healthcare cycles. The stability of this ratio confirms the high protection and quality of the capital assets.

Direct competitors

BSX - Market Cap to Net Assets Ratio|EW (edwards.com) - Market Cap to Book Value Multiple|RMD: Market Value to Book Value Ratio|Market Capitalization to Book Value PODD|ZBH - Market Value to Book Value Ratio|Market Capitalization to Net Assets CooperSurgical (COO)|ALGN: Market Capitalization to Book Value Ratio|Market-to-Book Ratio globusmedical.com GMED|TMDX: Market Capitalization to Book Value Ratio|ATEC - Market Cap to Net Assets Ratio|Artivion Inc - Market Capitalization to Book Value Ratio|Enovis Inc. (ENOV) - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ESTA|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRADIMED Corp (IRMD)|Market Capitalization to Book Value Ratio EMBC|TNDM - Market Capitalization to Book Value|Market Cap to Net Assets Ratio AxoGen, Inc.|SIBN - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio OFIX|Bioventus Inc (BVS) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio OrthoPediatrics Corp (KIDS)|Capitalization to Book Value Ratio Treace Corp (TMCI)|Strata Critical Medical Inc (SRTA) - Market Cap to Net Assets Ratio|Market Value to Book Value CARL (carlsmed.com)|RxSight - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio ClearPoint Neuro Inc. CLPT|STXS (Stereotaxis Corp) - Market Capitalization to Book Value Ratio|STIM - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Sight Sciences, Inc.|orchestrabiomed.com (OBIO) - Capitalization to Book Value Ratio|ANIK: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value InspireMD Inc|Market Capitalization to Book Value Ratio ZJYL (Jin Medical International)|Market Cap to Net Assets Ratio vivani.com (VANI)|Market Capitalization to Book Value Ratio XTNT (Xtant Medical)|n1mtc.com - Market Capitalization to Book Value Ratio|MODD - Market Value to Book Value Ratio|Myomo Inc. (MYO) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Envoy Medical, Inc COCH|Vivos Therapeutics Inc (VVOS) - Market Value to Book Value|Market Capitalization to Book Value Ratio NVNO (enVVeno Medical)|Market-to-Book Ratio SINT|TNON: Market Value to Book Value Ratio|Market Value to Equity Ratio ReWalk Robotics LFWD|Market Cap to Net Assets Ratio AMIX (Autonomix Medical)|Market Capitalization to Book Value Ratio INVO Fertility Corp IVF|Market Capitalization to Book Value Ratio BBLG (Bone Biologics)|AXNX: Market Capitalization to Book Value|Market Value to Book Value Ratio BIOLASE (BIOL)|FNA (Paragon 28) - Market Capitalization to Net Assets|Market Value to Book Value Ratio INVO